Dependence in Biological Technology
Navigation Links
Dependence in Biological Technology
Human Genome Sciences Announces Closing of Public Offering
... Genome Sciences' unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... property protection, Human Genome Sciences' dependence on key management and key suppliers, the ...Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
... regulation of the pharmaceutical industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to ... litigation or claims by the government; our dependence on sales to a limited number of large pharmacy ...Neurocrine Biosciences Reports Second Quarter 2009 Results
... trials; and risks associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
... Genome Sciences' unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... property protection, Human Genome Sciences' dependence on key management and key suppliers, the ...Human Genome Sciences Announces Proposed Public Offering of Common Stock
... Genome Sciences' unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... property protection, Human Genome Sciences' dependence on key management and key suppliers, the ...Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... #P3-221: Predicting Costs of Care for Unique dependence Levels in Patients with AD (Murman DL, et al.) ... relationship between total costs and AD dependence levels, with costs increasing significantly with increasing dependence. In this study, dependence level provided a useful method to estimate unique ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... market opportunity for Helix's products; Helix's dependence on its contractors, consultants, advisors and ... the drug candidate and on the Company; Helix's dependence on its licensor of the L-DOS47 antibody; the need ... which may arise out of DOS47; the Company's dependence on a few customers and a few suppliers, the loss ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
DuPont Innovation Addressing Major Global Market Trends
... in Increasing Food Productivity, Decreasing dependence on Fossil Fuels, Protecting Lives, Growing in ... for increasing food productivity, decreasing dependence on fossil fuels, protecting lives and growing in ... of increasing food productivity, decreasing dependence on fossil fuels and protecting lives. With ...Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Neurocrine Biosciences Reports First Quarter 2009 Results
... trials; risks associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
... regulation of the pharmaceutical industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to ... litigation or claims by the government; our dependence on sales to a limited number of large pharmacy ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Human Genome Sciences to Sponsor Conference Call
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Human Genome Sciences Appoints David P. Southwell to its Board of Directors
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...ViroPharma To Acquire Lev Pharmaceuticals
... a biologics license has been applied, our heavy dependence on the success of Cinryze(TM), our dependence on our suppliers, our dependence on third parties to manufacture Cinryze(TM), ...Indevus Receives Approvable Letter from FDA for NEBIDO(R)
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Indevus Announces Management Changes
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...
Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Other ContentsligaseligaseligasereactionsreactionsreactionsreactionsreactionsreactionsreactionsreactionsreactionsligationligationligationligationligationligationlimblimblimblimblimblimblimblimblineagelineagelineagelineagedisequilibriumlinkagelinkagelinkagelinkagelinkagelinkerlinkerlinkerOther TagsinterlockDialDialLinersAcetabularTaper
(Date:11/26/2009)..., Mass. (November 26, 2009) Whitehead researchers...uman cells to pinpoint specific genes and proteins...cience . , In most human cell cultures genes are...her and one from the mother. Gene inactivation by ... copy is inactivated, the second copy usually rema...
(Date:11/25/2009)...a hormone produced in the stomach, may be used to ...arkinson,s disease, Yale School of Medicine resear...e of the Journal of Neuroscience . , Parkinson,...neurons in an area of the midbrain known as the su...production. Reduced production of dopamine in lat...
(Date:11/25/2009)...WI, NOVEMBER 25, 2009 Soil is the linchpin of the...rosphere meet. Despite that, many students see soi...ing more. Soil science educators are challenged wi...ognize the critical importance of soil in the envi...nce and earth science teachers at University of Ne...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer High Quality Care to the Community 13720 1Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer High Quality Care to the Community 13720 2Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer High Quality Care to the Community 13720 3Two Lehigh Valley Healthcare Leaders Collaborate to Deliver Safer High Quality Care to the Community 13720 4President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 1President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 2NIH grant advances Tay Sachs disease gene therapy 55522 1NIH grant advances Tay Sachs disease gene therapy 55522 2NIH grant advances Tay Sachs disease gene therapy 55522 3(Date:11/26/2009)...e number of Americans living with diabetes will ne...to 44.1 million in 2034. Over the same period, spe...$113 billion to $336 billion, even with no increas...at the University of Chicago report in the Decembe...e with diabetes covered by Medicare will rise from...
(Date:11/26/2009)...hen on an emotional rollercoaster, study finds , ...all it the fear factor meets the jubilant sports f...specially those who root for the winning team -- e...ontested match and victory was in doubt, producing...that this Thanksgiving weekend as you,re glued to ...
(Date:11/26/2009)...Research Triangle Dental (RTDental), a leading den...y announced the expansion of its services to inclu...Doug Macmillan. , Durh...sed to announce that Dr. Doug Macmillan, an experi...dditional advanced training seminar. RTDental&rsq...
(Date:11/25/2009).../PRNewswire-USNewswire/--Whenmostpeopleheartheacro...alsogivepatientsthehelptheyneed.TMJstandsfortheTem...)contacts/connectswithyourskull(temporalbone). ,...onarepainwithchewing,clickingorpoppingofthejaw.But...uding:headaches,fatigue,sleepdisturbances,irritabi...
(Date:11/25/2009)...Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadingm...softwareandCalgaryScientificInc.,aleadingprovidero...rsionofAegis(TM)Breast4DAdvancedVisualizationsoftw...ero-footprintWebclientbasedmedicalimagingofferingi...llowsforzero-footprintaccess-requiringnosoftwaredo...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3[0] Diabetes cases to double and costs to triple by 2034[0] Watching the Nail-Biting Big Game Hurts So Good[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [1] TMJ and Chiropractic Care: An Overall Wellness Approach[1] Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology
interlockProvidentProtractDialLinersAcetabularTaperfinnedCoCrinterlokRotationalEndomodelPosteriorlyLCS
Other Tagsscar 2scar 3scar 4arrhythmia 2combine 2combine 3combine 4combine 5combine 6combining 2combining 3combining 4combining 5combining 6combining 7combining 8combining 9delivers 2carrier 2tip 2tip 3tip 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |